Stock Earnings

Question 1

What are GT Biopharma Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), GT Biopharma Inc has a total asset of $4, Net loss of $-13

Question 2

What are the key financial ratios for GTBP?

Accepted Answer

GT Biopharma Inc's Current ratio is 0.8, has a Net margin is 0, sales per share of $0.

Question 3

How is GT Biopharma Inc's revenue broken down by segment or geography?

Accepted Answer

Currently GT Biopharma Inc data is not available.

Question 4

Is GT Biopharma Inc profitable?

Accepted Answer

no, according to the latest financial statements, GT Biopharma Inc has a net loss of $-13

Question 5

Does GT Biopharma Inc have any liabilities?

Accepted Answer

yes, GT Biopharma Inc has liability of 5

Question 6

How many outstanding shares for GT Biopharma Inc?

Accepted Answer

GT Biopharma Inc has a total outstanding shares of 2.23

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	--	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	--	8	7	12	47	6
Research & Development	--	5	6	8	9	0
Operating Expenses	--	14	13	21	57	6
Other Non Operating Income (Expenses)	--	0	4	0	0	-13
Pretax Income	--	-13	-7	-20	-58	-28
Income Tax Expense	--	--	--	--	--	--
Net Income	--	-13	-7	-20	-58	-28
Net Income Growth	--	86%	-65%	-66%	107%	-26%
Shares Outstanding (Diluted)	--	1.89	1.34	1.06	0.93	0.14
Shares Change (YoY)	--	41%	27%	13%	542%	30%
EPS (Diluted)	--	-6.93	-5.64	-19.66	-61.81	-193.54
EPS Growth	--	23%	-71%	-68%	-68%	-44%
Free Cash Flow	-10	-12	-8	-15	-15	-7
Free Cash Flow Per Share	--	-6.32	-5.93	-14.12	-15.98	-47.87
Gross Margin	--	--	--	--	--	--
Operating Margin	--	0%	0%	0%	0%	0%
Profit Margin	--	0%	0%	0%	0%	0%
Free Cash Flow Margin	--	0%	0%	0%	0%	0%
EBITDA	--	--	--	--	--	-6
EBITDA Margin	--	--	--	--	--	0%
D&A For EBITDA	--	--	--	--	--	0
EBIT	--	-14	-13	-21	-57	-6
EBIT Margin	--	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

GT Biopharma Inc (GTBP) Price